February 21, 2025

Oyster Proteins Supercharge Common Antibiotics' Power

New research reveals that antimicrobial proteins extracted from Sydney Rock Oyster hemolymph can enhance conventional antibiotic effectiveness up to 32-fold against drug-resistant bacteria while showing no toxicity to human cells.

Conexiant

February 21, 2025

CDC: Measles Cases Surge Amid Texas Outbreak

Measles cases in the U.S. surged from 14 to 93 in one week, with 95% of infections in unvaccinated or immunity-unknown individuals, per the CDC.

Reuters

February 21, 2025

Study Finds Diabetes Fuels Antibiotic Resistance

A study in Science Advances shows diabetes accelerates antibiotic resistance in Staphylococcus aureus infections, highlighting hyperglycemia's role in promoting resistant bacterial strains.

Conexiant

February 20, 2025

18-Year Neuroblastoma Remission in a Patient After GD2 CAR T-Cell Therapy

"She has never required any other therapy and is likely the longest-surviving patient with cancer who received [CAR T-cell] therapy."

Conexiant

February 18, 2025

FDA Clears Aptima SARS-CoV-2 Assay for High-Throughput Testing

FDA grants 510(k) clearance for Hologic’s Aptima SARS-CoV-2 assay, which uses the Panther system for high-throughput RNA detection.

Conexiant

February 17, 2025

Skin Metabolism and Exudation Limit Tattoo Ink Absorption, Study Finds

Researchers examined systemic absorption, metabolism, and excretion of tattoo ink tracers, providing evidence for a cutaneous first-pass effect and measuring systemic exposure levels.

Conexiant

February 17, 2025

FDA Approves GSK’s 5-in-1 MenABCWY Vaccine

FDA approves GSK’s Penmenvy, a 5-in-1 meningococcal vaccine for adolescents and young adults, targeting five major serogroups of Neisseria meningitidis that cause invasive meningococcal disease.

Conexiant

February 14, 2025

CDC Cuts 1,300 Workers Amid Overhaul

Nearly 1,300 probationary CDC workers are being dismissed as part of a federal workforce reduction.

Reuters

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant